Evidence map›Paper›PMID 40781085›Full record

ArticleNPJ Parkinson's disease2025

Online prediction of optimal deep brain stimulation contacts from local field potentials in Parkinson's disease.

Marjolein Muller, Stefano Scafa, Ibrahem Hanafi, Camille Varescon, Chiara Palmisano, Saskia van der Gaag, Rodi Zutt, Niels A van der Gaag, Carel F E Hoffmann, Jocelyne Bloch and 6 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marjolein MullerDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Stefano ScafaDepartment of Clinical Neurosciences, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
Ibrahem HanafiDepartment of Neurology, University Hospital of Wuerzburg and Julius Maximilian University of Wuerzburg, Wuerzburg, Germany.
Camille VaresconDepartment of Clinical Neurosciences, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
Chiara PalmisanoDepartment of Neurology, University Hospital of Wuerzburg and Julius Maximilian University of Wuerzburg, Wuerzburg, Germany.
Saskia van der GaagDepartment of Neurology, Haga Teaching Hospital, The Hague, the Netherlands.
Rodi ZuttDepartment of Neurology, Haga Teaching Hospital, The Hague, the Netherlands.
Niels A van der GaagDepartment of Neurosurgery, Haga Teaching Hospital, The Hague, the Netherlands.
Carel F E HoffmannDepartment of Neurosurgery, Haga Teaching Hospital, The Hague, the Netherlands.
Jocelyne BlochDefitech Center for Interventional Neurotherapies (NeuroRestore), University Hospital Lausanne and Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Mayte Castro JiménezService of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Julien F BallyService of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Philipp CapetianDepartment of Neurology, University Hospital of Wuerzburg and Julius Maximilian University of Wuerzburg, Wuerzburg, Germany.
Ioannis U IsaiasDepartment of Neurology, University Hospital of Wuerzburg and Julius Maximilian University of Wuerzburg, Wuerzburg, Germany.
Eduardo M Moraud *Department of Clinical Neurosciences, University Hospital Lausanne (CHUV), Lausanne, Switzerland.
M Fiorella Contarino *Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. m.f.contarino@lumc.nl.

Funding

Deutsche Forschungsgemeinschaft 424778381 - TRR 295HORIZON EUROPE European Innovation Council 101070865 (Minigraph)NextGenerationEU NRRP M6C2 - Investment 2.1
6 · The paper itself

Abstract

Selecting optimal contacts for chronic deep-brain stimulation (DBS) requires a monopolar review, involving time-consuming manual testing by trained personnel, often causing patient discomfort. Neural biomarkers, such as local field potentials (LFP), could streamline this process. This study aimed to validate LFP recordings from chronically implanted neurostimulators for guiding clinical contact-level selection. We retrospectively analysed bipolar LFP recordings from Parkinson's disease patients across three centres (Netherlands: 68, Switzerland: 21, Germany: 32). Using beta-band power measures (13-35 Hz), we ranked channels based on clinical contact-level choices and developed two prediction algorithms: (i) a "decision tree" method for in-clinic use and (ii) a "pattern based" method for offline validation. The "decision tree" method achieved accuracies of 86.5% (NL), 86.7% (CH), and 75.0% (DE) for predicting the top two contact-levels. Both methods outperformed an existing algorithm. These findings suggest LFP-based approaches can enhance DBS programming efficiency, potentially reducing patient burden and clinical workload.

Identifiers

PMID40781085
PMCPMC12334580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.